Terms: = Thyroid cancer AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406
13 results:
1. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
[TBL] [Abstract] [Full Text] [Related]
2. Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations.
Sejben A; Pancsa T; Tiszlavicz L; Furák J; Paróczai D; Zombori T
Thorac Cancer; 2023 Apr; 14(10):857-863. PubMed ID: 36808895
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Survival-Related Metabolic Genes and a Novel Gene Signature Predicting the Overall Survival for Patients with Uveal Melanoma.
Guo X; Yu X; Li F; Xia Q; Ren H; Chen Z; Xing Y
Ophthalmic Res; 2022; 65(5):516-528. PubMed ID: 35390784
[TBL] [Abstract] [Full Text] [Related]
4. Squamous differentiation in surgically resected malignant pleural mesothelioma with neoadjuvant chemotherapy.
Yotsukura M; Motoi N; Yoshida A; Yoshida Y; Nakagawa K; Watanabe SI
Pathol Int; 2021 Oct; 71(10):692-696. PubMed ID: 34255921
[TBL] [Abstract] [Full Text] [Related]
5. Pseudocarcinomatous Mesothelioma: A Hitherto Unreported Presentation closely simulating primary lung cancer.
Rossi G; Caroli G; Caruso D; Stella F; Davoli F
Int J Surg Pathol; 2021 Oct; 29(7):775-779. PubMed ID: 33624546
[TBL] [Abstract] [Full Text] [Related]
6. Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for cancer and Neurodegeneration.
Sharma A; Liu H; Tobar-Tosse F; Chand Dakal T; Ludwig M; Holz FG; Loeffler KU; Wüllner U; Herwig-Carl MC
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486284
[TBL] [Abstract] [Full Text] [Related]
7. Basal cell carcinomas developing independently from bap1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with bap1-TPDS.
Melzer C; Sharma A; Peters S; Aretz S; Biswas A; Holz FG; Loeffler KU; Herwig-Carl MC
Genes Chromosomes Cancer; 2019 Jun; 58(6):357-364. PubMed ID: 30578689
[TBL] [Abstract] [Full Text] [Related]
8. Next generation immunohistochemistry: Emerging substitutes to genetic testing?
Andrici J; Gill AJ; Hornick JL
Semin Diagn Pathol; 2018 May; 35(3):161-169. PubMed ID: 28662997
[TBL] [Abstract] [Full Text] [Related]
9. Improving the Accuracy of Mesothelioma Diagnosis in China.
Guo Z; Carbone M; Zhang X; Su D; Sun W; Lou J; Gao Z; Shao D; Chen J; Zhang G; Hu J; Chen K; Wang F; Pass HI; Yu H; Napolitano A; Yang H; Mao W
J Thorac Oncol; 2017 Apr; 12(4):714-723. PubMed ID: 28007630
[TBL] [Abstract] [Full Text] [Related]
10. Positive nuclear bap1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Carbone M; Shimizu D; Napolitano A; Tanji M; Pass HI; Yang H; Pastorino S
Oncotarget; 2016 Sep; 7(37):59314-59321. PubMed ID: 27447750
[TBL] [Abstract] [Full Text] [Related]
11. Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
Lim SM; Park HS; Kim S; Kim S; Ali SM; Greenbowe JR; Yang IS; Kwon NJ; Lee JL; Ryu MH; Ahn JH; Lee J; Lee MG; Kim HS; Kim H; Kim HR; Moon YW; Chung HC; Kim JH; Kang YK; Cho BC
Oncotarget; 2016 Mar; 7(9):10547-56. PubMed ID: 26859683
[TBL] [Abstract] [Full Text] [Related]
12. A novel bap1 mutation is associated with melanocytic neoplasms and thyroid cancer.
McDonnell KJ; Gallanis GT; Heller KA; Melas M; Idos GE; Culver JO; Martin SE; Peng DH; Gruber SB
Cancer Genet; 2016 Mar; 209(3):75-81. PubMed ID: 26774355
[TBL] [Abstract] [Full Text] [Related]
13. Deubiquitinases and the new therapeutic opportunities offered to cancer.
Pfoh R; Lacdao IK; Saridakis V
Endocr Relat Cancer; 2015 Feb; 22(1):T35-54. PubMed ID: 25605410
[TBL] [Abstract] [Full Text] [Related]